Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia

Background: The aim of this study was to translate and cross-culturally adapt the international prostate symptom score (IPSS) and benign prostatic hyperplasia impact index (BII) into simplified Chinese for mainland Chinese patients with benign prostatic hyperplasia (BPH). Methods: The original Engli...

Full description

Bibliographic Details
Main Authors: Rong-liang Dun, Jian-min Mao, Chao Yu, Qiang Zhang, Xiao-hua Hu, Wen-jing Zhu, Guang-chong Qi, Yu Peng
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Prostate International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2287888222000186
_version_ 1797709901340868608
author Rong-liang Dun
Jian-min Mao
Chao Yu
Qiang Zhang
Xiao-hua Hu
Wen-jing Zhu
Guang-chong Qi
Yu Peng
author_facet Rong-liang Dun
Jian-min Mao
Chao Yu
Qiang Zhang
Xiao-hua Hu
Wen-jing Zhu
Guang-chong Qi
Yu Peng
author_sort Rong-liang Dun
collection DOAJ
description Background: The aim of this study was to translate and cross-culturally adapt the international prostate symptom score (IPSS) and benign prostatic hyperplasia impact index (BII) into simplified Chinese for mainland Chinese patients with benign prostatic hyperplasia (BPH). Methods: The original English IPSS and BII were translated into simplified Chinese versions based on cross-cultural adaptation guidelines. Internal consistency was evaluated with Cronbach’s α, then test-retest reliability with intraclass correlation coefficients (ICCs) in stable patients. The validity of these two adaptations was tested by the correlation between the IPSS and BII with visual prostate symptom score (VPSS) and 36 items Short Form Health Survey (SF-36). The floor and ceiling effects were calculated by the proportion of participants who obtained the highest and lowest possible score. Results: A total of 105 native Chinese-speaking patients with BPH were enrolled. Cronbach’s α was over 0.75 for the simplified Chinese IPSS (IPSS 0.815; IPSS-symptom 0.782) and 0.709 for the simplified Chinese BII, indicating acceptable internal consistency. The ICCs for the test-retest reliability were over 0.75 (IPSS, r = 0.836; IPSS-symptom, r = 0.801; IPSS-quality of life, r = 0.794; BII, r = 0.758), indicating excellent test-retest reliability. There were very good positive correlations between IPSS and BII (r = 0.605), as well as VPSS (r = 0.634), and very good or good negative correlations between IPSS-Qol and SF-36 physical functioning (r = −0.621), and vitality (r = −0.659), and between BII and SF-36 physical functioning (r = −0.421). No floor or ceiling effect was detected in the simplified Chinese IPSS and BII. Conclusions: This study indicates that the simplified Chinese IPSS and BII are reliable and valid measurements of the symptom and quality of life among Chinese patients with BPH, which is likely to be widely used in this population.
first_indexed 2024-03-12T06:44:32Z
format Article
id doaj.art-ce59ebc5da384296ac7d86020ca5e4c8
institution Directory Open Access Journal
issn 2287-8882
language English
last_indexed 2024-03-12T06:44:32Z
publishDate 2022-09-01
publisher Elsevier
record_format Article
series Prostate International
spelling doaj.art-ce59ebc5da384296ac7d86020ca5e4c82023-09-03T00:46:24ZengElsevierProstate International2287-88822022-09-01103162168Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasiaRong-liang Dun0Jian-min Mao1Chao Yu2Qiang Zhang3Xiao-hua Hu4Wen-jing Zhu5Guang-chong Qi6Yu Peng7Urology Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaAndrology, Shanghai Seventh People’s Hospital, Shanghai, ChinaUrology Surgery, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaUrology Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaUrology Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaUrology Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaUrology Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaUrology Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China; Corresponding author. Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Hospital, 110 Ganhe Road, Shanghai 200437, China.Background: The aim of this study was to translate and cross-culturally adapt the international prostate symptom score (IPSS) and benign prostatic hyperplasia impact index (BII) into simplified Chinese for mainland Chinese patients with benign prostatic hyperplasia (BPH). Methods: The original English IPSS and BII were translated into simplified Chinese versions based on cross-cultural adaptation guidelines. Internal consistency was evaluated with Cronbach’s α, then test-retest reliability with intraclass correlation coefficients (ICCs) in stable patients. The validity of these two adaptations was tested by the correlation between the IPSS and BII with visual prostate symptom score (VPSS) and 36 items Short Form Health Survey (SF-36). The floor and ceiling effects were calculated by the proportion of participants who obtained the highest and lowest possible score. Results: A total of 105 native Chinese-speaking patients with BPH were enrolled. Cronbach’s α was over 0.75 for the simplified Chinese IPSS (IPSS 0.815; IPSS-symptom 0.782) and 0.709 for the simplified Chinese BII, indicating acceptable internal consistency. The ICCs for the test-retest reliability were over 0.75 (IPSS, r = 0.836; IPSS-symptom, r = 0.801; IPSS-quality of life, r = 0.794; BII, r = 0.758), indicating excellent test-retest reliability. There were very good positive correlations between IPSS and BII (r = 0.605), as well as VPSS (r = 0.634), and very good or good negative correlations between IPSS-Qol and SF-36 physical functioning (r = −0.621), and vitality (r = −0.659), and between BII and SF-36 physical functioning (r = −0.421). No floor or ceiling effect was detected in the simplified Chinese IPSS and BII. Conclusions: This study indicates that the simplified Chinese IPSS and BII are reliable and valid measurements of the symptom and quality of life among Chinese patients with BPH, which is likely to be widely used in this population.http://www.sciencedirect.com/science/article/pii/S2287888222000186Benign prostatic hyperplasiaCross-cultural adaptationPsychometricQuality of lifeQuestionnaires
spellingShingle Rong-liang Dun
Jian-min Mao
Chao Yu
Qiang Zhang
Xiao-hua Hu
Wen-jing Zhu
Guang-chong Qi
Yu Peng
Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia
Prostate International
Benign prostatic hyperplasia
Cross-cultural adaptation
Psychometric
Quality of life
Questionnaires
title Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia
title_full Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia
title_fullStr Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia
title_full_unstemmed Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia
title_short Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia
title_sort simplified chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index cross cultural adaptation reliability and validity for patients with benign prostatic hyperplasia
topic Benign prostatic hyperplasia
Cross-cultural adaptation
Psychometric
Quality of life
Questionnaires
url http://www.sciencedirect.com/science/article/pii/S2287888222000186
work_keys_str_mv AT rongliangdun simplifiedchineseversionoftheinternationalprostatesymptomscoreandthebenignprostatichyperplasiaimpactindexcrossculturaladaptationreliabilityandvalidityforpatientswithbenignprostatichyperplasia
AT jianminmao simplifiedchineseversionoftheinternationalprostatesymptomscoreandthebenignprostatichyperplasiaimpactindexcrossculturaladaptationreliabilityandvalidityforpatientswithbenignprostatichyperplasia
AT chaoyu simplifiedchineseversionoftheinternationalprostatesymptomscoreandthebenignprostatichyperplasiaimpactindexcrossculturaladaptationreliabilityandvalidityforpatientswithbenignprostatichyperplasia
AT qiangzhang simplifiedchineseversionoftheinternationalprostatesymptomscoreandthebenignprostatichyperplasiaimpactindexcrossculturaladaptationreliabilityandvalidityforpatientswithbenignprostatichyperplasia
AT xiaohuahu simplifiedchineseversionoftheinternationalprostatesymptomscoreandthebenignprostatichyperplasiaimpactindexcrossculturaladaptationreliabilityandvalidityforpatientswithbenignprostatichyperplasia
AT wenjingzhu simplifiedchineseversionoftheinternationalprostatesymptomscoreandthebenignprostatichyperplasiaimpactindexcrossculturaladaptationreliabilityandvalidityforpatientswithbenignprostatichyperplasia
AT guangchongqi simplifiedchineseversionoftheinternationalprostatesymptomscoreandthebenignprostatichyperplasiaimpactindexcrossculturaladaptationreliabilityandvalidityforpatientswithbenignprostatichyperplasia
AT yupeng simplifiedchineseversionoftheinternationalprostatesymptomscoreandthebenignprostatichyperplasiaimpactindexcrossculturaladaptationreliabilityandvalidityforpatientswithbenignprostatichyperplasia